SDC2 is a member of the syndecan family and has been reported to play a critical role either as a tumor suppressor, such as in osteosarcoma (Mansouri et al., 2015), or as an oncogene, such as in breast cancer (Loftus et al., 2021). This evidence concerns the gene SDC2 and osteosarcoma.